Surgical Perspectives in Head and Neck Cancer

Chapter
Part of the Cancer Treatment and Research book series (CTAR, volume 174)

Abstract

Head and neck cancer treatment is a complex multidisciplinary undertaking. Cancer cure and survival is a primary goal, yet safe-guarding appearance and function to preserve the quality of life are similarly critical. The head and neck surgeon remains central to multidisciplinary cancer care, with deep knowledge of operative technique and an even deeper understanding of cancer biology. The surgeon models practice based on the highest levels of scientific evidence, but also takes into consideration the approaches that may best suit an individual patient. The surgeon's role moreover spans the life history of a head and neck cancer patient, from diagnosis to surveillance. The intimacy of this role makes the surgeon a trusted and frequent frame of reference for the patient. In this chapter, we provide an overview of the surgeon's role in head and neck cancer management. We discuss surgical perspectives within the multidisciplinary care team and selectively highlight some of the more provocative clinical scenarios in the field.

Keywords

Head and neck surgical oncology Head and neck surgeon Head and neck cancer Multidisciplinary care Quality of life Role of surgeon 

References

  1. 1.
    Brunner M, Gore SM, Read RL et al (2015) Head and neck multidisciplinary team meetings: effect on patient management. Head Neck 37(7):1046–1050CrossRefPubMedGoogle Scholar
  2. 2.
    Licitra L, Keilholz U, Tahara M et al (2016) Evaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancer. Oral Oncol 59:73–79CrossRefPubMedGoogle Scholar
  3. 3.
    Wheless SA, McKinney KA, Zanation AM (2010) A prospective study of the clinical impact of a multidisciplinary head and neck tumor board. Otolaryngol Head Neck Surg: Off J Am Acad Otolaryngol Head Neck Surg 143(5):650–654CrossRefGoogle Scholar
  4. 4.
    Rosenthal DI, Liu L, Lee JH et al (2002) Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck 24(2):115–126CrossRefPubMedGoogle Scholar
  5. 5.
    Murphy CT, Galloway TJ, Handorf EA et al (2016) Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol 34(2):169–178CrossRefPubMedGoogle Scholar
  6. 6.
    Zanoni DK, Migliacci JC, Xu B et al (2017) Proposal to redefine close surgical margins in squamous cell carcinoma of the oral tongue. JAMA Otolaryngol Head Neck Surg 143(6):555–560Google Scholar
  7. 7.
    Cerezo L, Millan I, Torre A, Aragon G, Otero J (1992) Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases. Cancer 69(5):1224–1234CrossRefPubMedGoogle Scholar
  8. 8.
    Ho AS, Kim S, Tighiouart M et al (2017) Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer. J Clin Oncol 35(31):3601–3609Google Scholar
  9. 9.
    Ho AS, Kim S, Tighiouart M et al (2017) Association of quantitative metastatic lymph node burden with survival in hypopharyngeal and laryngeal cancer. JAMA Oncol.  https://doi.org/10.1001/jamaoncol.2017.3852. [Epub ahead of print]
  10. 10.
    Kun-Darbois JD, Breheret R, Bizon A, Pare A, Laccourreye L (2015) Bronchogenic cyst of the tip of the tongue: report of two cases. Eur Ann Otorhinolaryngol Head Neck Dis 132(1):49–51CrossRefPubMedGoogle Scholar
  11. 11.
    D’Cruz AK, Vaish R, Kapre N et al (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373(6):521–529CrossRefPubMedGoogle Scholar
  12. 12.
    Gutiontov SI, Shin EJ, Lok B, Lee NY, Cabanillas R (2016) Intensity-modulated radiotherapy for head and neck surgeons. Head Neck 38(Suppl 1):2368–2373CrossRefGoogle Scholar
  13. 13.
    Argiris A, Harrington KJ, Tahara M et al (2017) Evidence-based treatment options in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Front Oncol 7:72CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Fakhry C, Zhang Q, Nguyen-Tan PF et al (2014) Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol Off J Am Soc Clin Oncol 32(30):3365–3373CrossRefGoogle Scholar
  15. 15.
    Ho AS, Tsao GJ, Chen FW et al (2013) Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer 119(7):1349–1356CrossRefPubMedGoogle Scholar
  16. 16.
    Mehanna H, Wong WL, McConkey CC et al (2016) PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J Med 374(15):1444–1454CrossRefPubMedGoogle Scholar
  17. 17.
    Adams G, Porceddu SV, Pryor DI et al (2014) Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET–guided neck management policy. Head Neck 36(8):1200–1206CrossRefPubMedGoogle Scholar
  18. 18.
    Fakhry N, Michel J, Colavolpe C, Varoquaux A, Dessi P, Giovanni A (2012) Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound. Clin Otolaryngol 37(3):197–206CrossRefPubMedGoogle Scholar
  19. 19.
    Ho AS, Kraus DH, Ganly I, Lee NY, Shah JP, Morris LG (2014) Decision making in the management of recurrent head and neck cancer. Head Neck 36(1):144–151CrossRefPubMedGoogle Scholar
  20. 20.
    Kurzweg T, Mockelmann N, Laban S, Knecht R (2012) Current treatment options for recurrent/metastatic head and neck cancer: a post-ASCO 2011 update and review of last year’s literature. Eur Arch Otorhinolaryngol Off J Eur Fed Otorhinolaryngol Soc 269(10):2157–2167CrossRefGoogle Scholar
  21. 21.
    Gourin CG, Watts T, Williams HT, Patel VS, Bilodeau PA, Coleman TA (2009) Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer. Laryngoscope 119(4):703–706CrossRefPubMedGoogle Scholar
  22. 22.
    Perlow A, Bui C, Shreve P, Sundgren PC, Teknos TN, Mukherji SK (2004) High incidence of chest malignancy detected by FDG PET in patients suspected of recurrent squamous cell carcinoma of the upper aerodigestive tract. J Comput Assist Tomogr 28(5):704–709CrossRefPubMedGoogle Scholar
  23. 23.
    Fury MG, Antonescu CR, Van Zee KJ, Brennan MF, Maki RG (2005) A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J 11(3):241–247CrossRefPubMedGoogle Scholar
  24. 24.
    Ogawa K, Takahashi K, Asato Y et al (1019) Treatment and prognosis of angiosarcoma of the scalp and face: a retrospective analysis of 48 patients. Br J Radiol 2012(85):1127–1133Google Scholar
  25. 25.
    Mullins B, Hackman T (2015) Angiosarcoma of the Head and Neck. Int Arch Otorhinolaryngol 19(3):191–195CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Holden CA, Spittle MF, Jones EW (1987) Angiosarcoma of the face and scalp, prognosis and treatment. Cancer 59(5):1046–1057CrossRefPubMedGoogle Scholar
  27. 27.
    Hutcheson KA, Holsinger FC, Kupferman ME, Lewin JS (2015) Functional outcomes after TORS for oropharyngeal cancer: a systematic review. Eur Arch Otorhinolaryngol Off J Eur Fed Otorhinolaryngol Soc (EUFOS) Aff Ger Soc Otorhinolaryngol Head Neck Surgery. 272(2):463–471Google Scholar
  28. 28.
    Hutcheson KA, Lewin JS, Barringer DA et al (2012) Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer 118(23):5793–5799CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Mehta V, Johnson P, Tassler A et al (2013) A new paradigm for the diagnosis and management of unknown primary tumors of the head and neck: a role for transoral robotic surgery. Laryngoscope 123(1):146–151CrossRefPubMedGoogle Scholar
  30. 30.
    Sinclair CF, McColloch NL, Carroll WR, Rosenthal EL, Desmond RA, Magnuson JS (2011) Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 137(11):1112–1116Google Scholar
  31. 31.
    de Almeida JR, Li R, Magnuson JS, et al (2015) Oncologic outcomes after transoral robotic surgery: a multi-institutional study. JAMA Otolaryngol Head Neck Surg 141(12):1043–1051Google Scholar
  32. 32.
    Cohen MA, Weinstein GS, O’Malley BW Jr, Feldman M, Quon H (2011) Transoral robotic surgery and human papillomavirus status: oncologic results. Head Neck 33(4):573–580CrossRefPubMedGoogle Scholar
  33. 33.
    Motz K, Chang HY, Quon H, Richmon J, Eisele DW, Gourin CG (2017) Association of transoral robotic surgery with short-term and long-term outcomes and costs of care in oropharyngeal cancer surgery. JAMA Otolaryngol Head Neck SurgGoogle Scholar
  34. 34.
    Chen AM, Daly ME, Luu Q, Donald PJ, Farwell DG (2015) Comparison of functional outcomes and quality of life between transoral surgery and definitive chemoradiotherapy for oropharyngeal cancer. Head Neck 37(3):381–385CrossRefPubMedGoogle Scholar
  35. 35.
    Moore EJ, Hinni ML (2013) Critical review: transoral laser microsurgery and robotic-assisted surgery for oropharynx cancer including human papillomavirus-related cancer. Int J Radiat Oncol Biol Phys 85(5):1163–1167CrossRefPubMedGoogle Scholar
  36. 36.
    Hurtuk AM, Marcinow A, Agrawal A, Old M, Teknos TN, Ozer E (2012) Quality-of-life outcomes in transoral robotic surgery. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 146(1):68–73CrossRefGoogle Scholar
  37. 37.
    Smallridge RC, Ain KB, Asa SL et al (2012) American thyroid association guidelines for management of patients with anaplastic thyroid cancer. Thyr Off J Am Thyr Assoc 22(11):1104–1139CrossRefGoogle Scholar
  38. 38.
    NCCN Guidelines - Thyroid carcinoma. 2017; Version 1.2017Google Scholar
  39. 39.
    Smallridge RC (2012) Approach to the patient with anaplastic thyroid carcinoma. J Clin Endocrinol Meta 97(8):2566–2572CrossRefGoogle Scholar
  40. 40.
    Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyr Off J Am Thyr Assoc 26(1):1–133CrossRefGoogle Scholar
  41. 41.
    Tufano RP, Clayman G, Heller KS et al (2015) Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance. Thyr Off J Am Thyr Assoc 25(1):15–27CrossRefGoogle Scholar
  42. 42.
    Starmer H, Noureldine SI, Ozgursoy OB, Tufano RP (2015) Voice outcomes following reoperative central neck dissection for recurrent/persistent thyroid cancer. Laryngoscope 125(11):2621–2625CrossRefPubMedGoogle Scholar
  43. 43.
    Vaisman F, Tala H, Grewal R, Tuttle RM (2011) In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response. Thyr Off J Am Thyr Assoc 21(12):1317–1322CrossRefGoogle Scholar
  44. 44.
    Mazzaferri EL, Robbins RJ, Spencer CA et al (2003) A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88(4):1433–1441CrossRefPubMedGoogle Scholar
  45. 45.
    Steward DL (2012) Update in utility of secondary node dissection for papillary thyroid cancer. J Clin Endocrinol Metab 97(10):3393–3398CrossRefPubMedGoogle Scholar
  46. 46.
    Yim JH, Kim WB, Kim EY et al (2011) The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab 96(7):2049–2056CrossRefPubMedGoogle Scholar
  47. 47.
    Schuff KG, Weber SM, Givi B, Samuels MH, Andersen PE, Cohen JI (2008) Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope 118(5):768–775CrossRefPubMedGoogle Scholar
  48. 48.
    Wu G, Fraser S, Pai SI, Farrag TY, Ladenson PW, Tufano RP (2012) Determining the extent of lateral neck dissection necessary to establish regional disease control and avoid reoperation after previous total thyroidectomy and radioactive iodine for papillary thyroid cancer. Head Neck 34(10):1418–1421CrossRefPubMedGoogle Scholar
  49. 49.
    Randolph GW, Duh QY, Heller KS et al (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyr Off J Am Thyr Assoc 22(11):1144–1152CrossRefGoogle Scholar
  50. 50.
    Machens A, Hinze R, Thomusch O, Dralle H (2002) Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26(1):22–28CrossRefPubMedGoogle Scholar
  51. 51.
    Noguchi S, Murakami N, Yamashita H, Toda M, Kawamoto H (1998) Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 133(3):276–280CrossRefPubMedGoogle Scholar
  52. 52.
    Nishida T, Nakao K, Hamaji M, Kamiike W, Kurozumi K, Matsuda H (1997) Preservation of recurrent laryngeal nerve invaded by differentiated thyroid cancer. Ann Surg 226(1):85–91CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Falk SA, McCaffrey TV (1995) Management of the recurrent laryngeal nerve in suspected and proven thyroid cancer. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 113(1):42–48CrossRefGoogle Scholar
  54. 54.
    Kiess AP, Agrawal N, Brierley JD et al (2016) External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society. Head Neck 38(4):493–498CrossRefPubMedGoogle Scholar
  55. 55.
    Hay ID, Charboneau JW (2011) The coming of age of ultrasound-guided percutaneous ethanol ablation of selected neck nodal metastases in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab 96(9):2717–2720CrossRefPubMedGoogle Scholar
  56. 56.
    Monchik JM, Donatini G, Iannuccilli J, Dupuy DE (2006) Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 244(2):296–304CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Stenson KM, Kunnavakkam R, Cohen EE et al (2010) Chemoradiation for patients with advanced oral cavity cancer. Laryngoscope 120(1):93–99PubMedGoogle Scholar
  58. 58.
    Chinn SB, Spector ME, Bellile EL et al (2013) Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 149(6):893–899CrossRefGoogle Scholar
  59. 59.
    Iyer NG, Tan DS, Tan VK et al (2015) Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis. Cancer 121(10):1599–1607CrossRefPubMedGoogle Scholar
  60. 60.
    Wong FK, Zumsteg ZS2, Langevin CJ et al (2017) Mucinous carcinoma with neuroendocrine differentiation of salivary gland origin. Head Neck Pathol 11(2):249–255Google Scholar
  61. 61.
    Department of Veterans Affairs Laryngeal Cancer Study G, Wolf GT, Fisher SG et al (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324(24):1685–1690Google Scholar
  62. 62.
    Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091–2098CrossRefPubMedGoogle Scholar
  63. 63.
    Forastiere AA, Zhang Q, Weber RS et al (2013) Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31(7):845–852CrossRefPubMedGoogle Scholar
  64. 64.
    List MA, Stracks J, Colangelo L et al (2000) How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? J Clin Oncol 18(4):877–884CrossRefPubMedGoogle Scholar
  65. 65.
    McNeil BJ, Weichselbaum R, Pauker SG (1981) Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med 305(17):982–987CrossRefPubMedGoogle Scholar
  66. 66.
    Laccourreye O, Malinvaud D, Menard M, Consoli S, Giraud P, Bonfils P (2014) Total laryngectomy or laryngeal preservation for advanced laryngeal cancer. Impact of the functional risk upon the patient’s preferences. Eur Ann Otorhinolaryngol Head Neck Dis 131(2):93–97CrossRefPubMedGoogle Scholar
  67. 67.
    Worden FP, Kumar B, Lee JS et al (2008) Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol 26(19):3138–3146CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    American Society of Clinical O, Pfister DG, Laurie SA et al (2006) American society of clinical oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24(22):3693–3704CrossRefGoogle Scholar
  69. 69.
    Levendag P, Sessions R, Vikram B et al (1989) The problem of neck relapse in early stage supraglottic larynx cancer. Cancer 63(2):345–348CrossRefPubMedGoogle Scholar
  70. 70.
    Chiu RJ, Myers EN, Johnson JT (2004) Efficacy of routine bilateral neck dissection in the management of supraglottic cancer. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg 131(4):485–488CrossRefGoogle Scholar
  71. 71.
    Rodrigo JP, Suarez C, Silver CE et al (2008) Transoral laser surgery for supraglottic cancer. Head Neck 30(5):658–666CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of SurgeryCedars-Sinai Medical CenterLos AngelesUSA
  2. 2.Department of Surgery, Division of Head and Neck SurgeryCity of Hope National Medical CenterDuarteUSA

Personalised recommendations